Recruiting for Protocols Where Almost Nobody Qualifies

Narrow-eligibility studies break the habits that work everywhere else. A broad hypertension trial rewards volume: push ads, answer calls, book screens. A study requiring a specific biomarker, a treatment-naive window, or a narrow washout punishes volume. You burn budget and coordinator hours on calls that were never going to qualify.

The shift is from casting a wide net to finding the handful of people who already exist in your records or your referral network.

Start by deconstructing the protocol

Before you write a single ad, sit down with the inclusion and exclusion list and sort every criterion into three buckets:

• Findable in data. Diagnosis codes, lab values, prescribed medications, age, prior procedures. These you can query.
• Askable on a call. Symptom duration, willingness to stop a medication, caregiver availability, travel distance.
• Only knowable at screening. Imaging reads, central lab confirmation, washout tolerance.

Most narrow studies have one or two criteria that eliminate the vast majority of candidates. Identify them. That single criterion should drive your entire strategy. If the study needs a documented eGFR in a specific band within the last six months, your recruitment problem is a records problem, not an advertising problem.

Query first, advertise last

For tight protocols, your own patient data and prior study participants are almost always the highest-yield source. Pull a list against the findable criteria, then work it manually. Sites commonly find that a single well-built query produces more qualified screens than weeks of paid media on the same protocol.

If you don't have EHR query access, build a workaround:

1. Ask your referring physicians for a list rather than a referral. "Send me your patients with X on Y therapy" is easier for them than remembering your study during a visit.
2. Mine your own screen failure and prior-participant records for the limiting criterion.
3. Check registries and patient advocacy groups tied to the specific condition.

Advertising still has a role, but target it against the limiting criterion rather than the disease. An ad that says "recently diagnosed, not yet started treatment" filters better than one naming the condition alone.

Redesign pre-screening for depth, not speed

With broad studies you want short calls. With narrow ones, you want the disqualifying questions in the first ninety seconds, then a genuinely thorough conversation with whoever survives. Put the limiting criterion as question one or two, even if it feels abrupt. Explain why you're asking — people tolerate specificity when it's framed as making sure the study is actually right for them.

For criteria that require records, start the records request during the first call. Get the releases signed same-day. Waiting until after a screening visit is scheduled is how narrow studies stall.

Set expectations with sponsors early

Narrow protocols produce ugly-looking funnel metrics: high pre-screen failure, low ad conversion, long time-to-first-enrollment. Tell the sponsor what your pre-screen-to-enroll ratio looks like on comparable protocols before the study opens, and report against it. A site that predicted a 20-to-1 ratio and delivered it reads as competent. A site that quietly misses enrollment looks like it under-performed.

Also push back during feasibility. If a criterion is hard to verify in your population, say so in writing. Sponsors sometimes have flexibility on lookback windows or acceptable lab sources, and they will only use it if sites raise the issue.

Protect coordinator morale

Narrow studies feel like failure day to day. Track pre-screens completed and records obtained, not just randomizations, so the team sees progress. One enrollment a month on a hard protocol can be excellent performance — make sure the people doing the work know that.